Latest Boston Scientific Corporation Stories
MARLBOROUGH, Mass., Sept. 2, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG.
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug.
Large, Prospective, Multi-National Study Examines Management of Benign Biliary Strictures with Fully Covered Self-Expanding Metal Stents after Extended Indwell MARLBOROUGH, Mass., Aug.
MALBOROUGH, Mass., Aug.
Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass.
High performance workspace design provides open, state-of-the-art office environment BOSTON, Aug.
MARLBOROUGH, Mass., July 24, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $1.873 billion during the second quarter ended June 30, 2014, compared to the company's
Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 /PRNewswire/ -- Continuing to advance the
Easy to Use Imaging System to Support Planned Intravascular Ultrasound and Fractional Flow Reserve Products MARLBOROUGH, Mass., July 22, 2014 /PRNewswire/ -- Boston Scientific Corporation
Advanced Bare-Metal Stent Provides Additional Treatment Option for Interventional Cardiologists and Patients MARLBOROUGH, Mass., July 21, 2014 /PRNewswire/ -- Boston Scientific Corporation
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.